Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis.

MLA

Ramiro, Sofia, et al. “Early Clinical Response Associates with Long-Term Outcomes with Ixekizumab in Radiographic Axial Spondyloarthritis.” RMD Open, vol. 10, no. 3, July 2024, pp. 1–8. EBSCOhost, https://doi.org/10.1136/rmdopen-2024-004429.

APA

Ramiro, S., Lukas, C., Bessette, L., Wickersham, P., Panni, T., Bolce, R., Soyi Liu-Leage, Janos, B., Nissen, M. J., & Cheng-Chung Wei, J. (2024). Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis. RMD Open, 10(3), 1–8. https://doi.org/10.1136/rmdopen-2024-004429

Chicago

Ramiro, Sofia, Cédric Lukas, Louis Bessette, Pendleton Wickersham, Tommaso Panni, Rebecca Bolce, Soyi Liu-Leage, Boris Janos, Michael J. Nissen, and James Cheng-Chung Wei. 2024. “Early Clinical Response Associates with Long-Term Outcomes with Ixekizumab in Radiographic Axial Spondyloarthritis.” RMD Open 10 (3): 1–8. doi:10.1136/rmdopen-2024-004429.